Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
BMJ Open Qual ; 7(3): e000035, 2018.
Article in English | MEDLINE | ID: mdl-30057948

ABSTRACT

Delivering high quality care in acute psychiatry requires a coordinated approach from a multidisciplinary team (MDT). Weekly ward rounds are an important forum for reviewing a patient's progress and developing a personalised care plan for the coming week. In general medicine, structured ward rounds and check lists have been shown to prevent omissions and improve patient safety; however, they are not widely used in psychiatry. At the Royal Edinburgh Hospital, the format of ward rounds differed between psychiatry wards and clinical teams, and care plans were not standardised. An audit in October 2015 found only 5% of acute psychiatric inpatients had a documented nursing care plan. It was agreed that a clear multidisciplinary care plan from the weekly ward round would be beneficial. A group of consultant psychiatrists identified seven key domains for ward round (Social needs, Community Mental Health Team liaison, Assessments required, Mental Health Act, Prescriptions: medication electroconvulsive therapy (ECT), T2/T3, Engagement with relatives and carers, Risk Assessment and Pass Plans). This was given the acronym SCAMPER. Following this, a clinical MDT on a paired male and female ward, developed and introduced a structured ward round sheet. Within 8 weeks this was being used for 100% of patients. It was subsequently introduced into three other acute adult psychiatry wards and the intensive psychiatric care unit. Staff feedback was sought verbally and via a questionnaire. This was positive. The form was widely accepted and staff felt it improved patient care and ward round quality.

2.
FP Essent ; 443: 11-5, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27092562

ABSTRACT

Appropriate screening for HIV infection is the cornerstone of HIV-related care. There have been several recent changes in testing technology and screening recommendations. The US Preventive Services Task Force recommends universal HIV screening at least once for adolescents and adults ages 15 to 65 years, and additional screening for patients at higher risk, although evidence is insufficient to determine optimum rescreening intervals. All pregnant women should be screened for HIV infection in the first trimester, and pregnant women at high risk should be screened again in the third trimester. The Centers for Disease Control and Prevention recommends use of an algorithm using fourth-generation tests for screening; this decreases the window period between infection and detection to as few as 14 days, thereby reducing the number of false-negative results. Home HIV testing kits, which require follow-up confirmatory testing, also are available. Clinicians should be aware of HIV-specific laws in their states, including those criminalizing HIV exposure and transmission. Thorough medical and laboratory evaluations are essential at initiation of care for patients with HIV infection, along with appropriate follow-up monitoring, as recommended in various guidelines.


Subject(s)
HIV Infections/diagnosis , Mass Screening/methods , RNA, Viral/blood , Viral Load , Adolescent , Adult , Aged , Algorithms , CD4 Lymphocyte Count , Criminal Law , Female , HIV Antibodies/immunology , HIV Core Protein p24/immunology , HIV Infections/blood , HIV Infections/immunology , HIV-1/immunology , HIV-2/immunology , Humans , Male , Middle Aged , Polymerase Chain Reaction , Practice Guidelines as Topic , Pregnancy , Reagent Kits, Diagnostic , Risk Assessment , Risk Factors , United States , Young Adult
3.
FP Essent ; 443: 16-22, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27092563

ABSTRACT

Care of patients with HIV infection starts with diagnosis as soon as possible, preferably at or near the time of acute infection. Opportunistic infections, malignancies, and other conditions develop progressively over time, particularly in untreated patients. The AIDS-defining opportunistic infections most common in the United States include Pneumocystis jirovecii pneumonia, Candida esophagitis, toxoplasmic encephalitis, tuberculosis, disseminated Mycobacterium avium complex, cryptococcal meningitis, and cytomegalovirus retinitis. Specific prophylaxis regimens exist for several opportunistic infections, and effective antiretroviral therapy reduces the risk of most others. Other AIDS-defining conditions include wasting syndrome and HIV encephalopathy. AIDS-defining malignancies include Kaposi sarcoma, systemic non-Hodgkin lymphoma, primary central nervous system lymphoma, and invasive cervical cancer. Although not an AIDS-defining condition, anal cancer is common in patients with HIV infection. Other HIV-related conditions include thrombocytopenia, recurrent bacterial respiratory infections, HIV-associated nephropathy, and HIV-associated neurocognitive disorder.


Subject(s)
AIDS Dementia Complex , AIDS-Associated Nephropathy , AIDS-Related Opportunistic Infections , HIV Infections , Neoplasms , Anus Neoplasms , Candidiasis , Central Nervous System Neoplasms , Comorbidity , Cytomegalovirus Retinitis , Esophageal Diseases , Female , Humans , Lymphoma , Lymphoma, Non-Hodgkin , Male , Mycobacterium avium-intracellulare Infection , Pneumonia, Pneumocystis , Sarcoma, Kaposi , Thrombocytopenia , Toxoplasmosis, Cerebral , Tuberculosis , United States , Uterine Cervical Neoplasms
4.
FP Essent ; 443: 23-30, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27092564

ABSTRACT

The advent of combination antiretroviral drug regimens has transformed HIV infection from a fatal illness into a manageable chronic condition. All patients with HIV infection should be considered for antiretroviral therapy, regardless of CD4 count or HIV viral load, for individual benefit and to prevent HIV transmission. Antiretroviral drugs affect HIV in several ways: entry inhibitors block HIV entry into CD4 T cells; nucleotide and nucleoside reverse transcriptase inhibitors prevent reverse transcription from RNA to DNA via chain-terminating proteins; nonnucleoside reverse transcriptase inhibitors prevent reverse transcription through enzymatic inhibition; integrase strand transfer inhibitors block integration of viral DNA into cellular DNA; protease inhibitors block maturation and production of the virus. Current guidelines recommend six combination regimens for initial therapy. Five are based on tenofovir and emtricitabine; the other uses abacavir and lamivudine. Five include integrase strand transfer inhibitors. HIV specialists should assist with treating patients with complicated HIV infection, including patients with treatment-resistant HIV infection, coinfection with hepatitis B or C virus, pregnancy, childhood infections, severe opportunistic infections, complex drug interactions, significant drug toxicity, or comorbidities. Family physicians can treat most patients with HIV infection effectively by choosing appropriate treatment regimens, monitoring patients closely, and retaining patients in care.


Subject(s)
HIV Fusion Inhibitors/therapeutic use , HIV Infections/drug therapy , HIV Integrase Inhibitors/therapeutic use , HIV Protease Inhibitors/therapeutic use , Reverse Transcriptase Inhibitors/therapeutic use , Antiretroviral Therapy, Highly Active , Dideoxynucleosides/therapeutic use , Drug Combinations , Drug Therapy, Combination , Emtricitabine/therapeutic use , Humans , Lamivudine/therapeutic use , Tenofovir/therapeutic use
5.
FP Essent ; 443: 31-42, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27092565

ABSTRACT

With the advent of antiretroviral therapy and improved access to care, the average life expectancy of patients with HIV infection receiving optimal treatment approaches that of patients in the general population. AIDS-related opportunistic infections and malignancies are no longer the primary issues; instead, traditional age- and lifestyle-related conditions are a growing concern. Patients with HIV infection are at higher risk of cardiovascular disease, diabetes, hypertension, and some non-AIDS-related cancers than patients in the general population. Family physicians need to be knowledgeable about screening for and managing chronic comorbid conditions as this population ages. Health maintenance, including appropriate vaccinations, prophylaxis against opportunistic infections, and routine screening for sexually transmitted infections, remains an important part of care. As HIV infection becomes a chronic condition, emerging strategies in prevention, including preexposure prophylaxis, fall within the scope of practice of the family physician.


Subject(s)
Cardiovascular Diseases/diagnosis , Diabetes Mellitus/diagnosis , HIV Infections/therapy , Hypertension/diagnosis , Neoplasms/diagnosis , Primary Health Care , Sexually Transmitted Diseases/diagnosis , AIDS-Related Opportunistic Infections/epidemiology , AIDS-Related Opportunistic Infections/prevention & control , Adult , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/therapy , Chronic Disease , Comorbidity , Diabetes Mellitus/epidemiology , Diabetes Mellitus/therapy , Early Detection of Cancer , HIV Infections/epidemiology , Hepatitis, Viral, Human/prevention & control , Humans , Hypertension/epidemiology , Hypertension/therapy , Influenza Vaccines/therapeutic use , Influenza, Human/epidemiology , Influenza, Human/prevention & control , Insulin Resistance , Male , Mass Screening , Neoplasms/epidemiology , Neoplasms/therapy , Papillomavirus Infections/epidemiology , Papillomavirus Infections/prevention & control , Papillomavirus Vaccines/therapeutic use , Sexually Transmitted Diseases/epidemiology , Viral Hepatitis Vaccines
6.
Acta Neurol Belg ; 111(3): 217-9, 2011 Sep.
Article in English | MEDLINE | ID: mdl-22141286

ABSTRACT

Multiple CNS infections can coexist in advanced AIDS, but are most commonly reported in autopsy case studies. We describe the case of an HIV+ individual, who was first diagnosed with CNS toxoplasmosis, confirmed by brain biopsy. After initiation of combined anti-retroviral therapy (cART) and successful treatment of CNS toxoplasmosis, he developed worsening neurological symptoms and was subsequently diagnosed with progressive multifocal leukoencephalopathy. Retrospective analysis of the MRI scans indicated that PML was already present early on but was interpreted as edema associated with CNS toxoplasmosis. Clinicians should be aware that multiple pathologies may coexist in the brain of immunosuppressed individuals and that PML may develop and worsen despite the use of cART.


Subject(s)
AIDS-Related Opportunistic Infections/diagnosis , Coinfection/diagnosis , Delayed Diagnosis , Leukoencephalopathy, Progressive Multifocal/diagnosis , Toxoplasmosis, Cerebral/diagnosis , AIDS-Related Opportunistic Infections/drug therapy , Adult , Anti-Retroviral Agents/therapeutic use , Antiprotozoal Agents/therapeutic use , Coinfection/drug therapy , Fatal Outcome , Humans , Leukoencephalopathy, Progressive Multifocal/drug therapy , Magnetic Resonance Imaging , Male
7.
J Med Chem ; 50(13): 2967-80, 2007 Jun 28.
Article in English | MEDLINE | ID: mdl-17536795

ABSTRACT

There remains a high unmet medical need for a safe oral therapy for thrombotic disorders. The serine protease factor Xa (fXa), with its central role in the coagulation cascade, is among the more promising targets for anticoagulant therapy and has been the subject of intensive drug discovery efforts. Investigation of a hit from high-throughput screening identified a series of thiophene-substituted anthranilamides as potent nonamidine fXa inhibitors. Lead optimization by incorporation of hydrophilic groups led to the discovery of compounds with picomolar inhibitory potency and micromolar in vitro anticoagulant activity. Based on their high potency, selectivity, oral pharmacokinetics, and efficacy in a rat venous stasis model of thrombosis, compounds ZK 814048 (10b), ZK 810388 (13a), and ZK 813039 (17m) were advanced into development.


Subject(s)
Amides/chemical synthesis , Aminopyridines/chemical synthesis , Anticoagulants/chemical synthesis , Factor Xa Inhibitors , Thiophenes/chemical synthesis , ortho-Aminobenzoates/chemical synthesis , Amides/pharmacokinetics , Amides/pharmacology , Aminopyridines/pharmacokinetics , Aminopyridines/pharmacology , Animals , Anticoagulants/pharmacokinetics , Anticoagulants/pharmacology , Crystallography, X-Ray , Dogs , Humans , In Vitro Techniques , Male , Models, Molecular , Prothrombin Time , Rats , Rats, Wistar , Structure-Activity Relationship , Thiophenes/pharmacokinetics , Thiophenes/pharmacology , Venous Thrombosis/drug therapy , ortho-Aminobenzoates/pharmacokinetics , ortho-Aminobenzoates/pharmacology
9.
Ann Thorac Surg ; 75(5): 1635-7, 2003 May.
Article in English | MEDLINE | ID: mdl-12735596

ABSTRACT

Splenic abscess is a rare clinical entity that is most commonly associated with infective endocarditis. Valve replacement in the setting of an unaddressed splenic abscess is associated with a high incidence of prosthetic valve infection and death. We describe 2 patients with infective endocarditis and splenic abscess treated by laparoscopic splenectomy followed by valve replacement.


Subject(s)
Abscess/surgery , Endocarditis, Bacterial/surgery , Heart Valve Prosthesis Implantation , Laparoscopy , Splenectomy , Splenic Diseases/surgery , Abscess/complications , Adult , Aged , Humans , Male , Splenic Diseases/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...